PeptideGLP-1GLP-1 Agonist

Reta+Cagri Blend

Combination (triple agonist + amylin analog: retatrutide + cagrilintide)

Typical dose

titrate together weekly

once weekly · SubQ · blend · potent

Half-life

~weekly

What is Reta+Cagri Blend?

Fixed blend of retatrutide and cagrilintide.

How Reta+Cagri Blend works

Pairs retatrutide (triple GLP-1/GIP/glucagon agonist) with cagrilintide (amylin analog) — four pathways at once. No approved protocol; investigational.

Benefits & uses

Targets four receptor pathways (GLP-1/GIP/glucagon + amylin)
Aims for maximal appetite/metabolic effect
Layered satiety mechanisms

Common uses: Aggressive fat loss / obesity (investigational combination).

Blend composition

Mix the 10 mg blend (5 mg + 5 mg) with 2 mL bac water → 2.5 mg each per mL. Titrate slowly.

Retatrutideper titration
Cagrilintideper titration

Reta+Cagri Blend dosage

Typical dose: Blend, dosed by volume — titrate together per protocol. Once weekly. Potent — titrate slowly.

Reta+Cagri Blend half-life

~weekly

Reta+Cagri Blend side effects

Nausea
Vomiting
Diarrhea
Delayed gastric emptying
Fatigue
Heart-rate increase

Warnings & monitoring

GI tolerability is the main short-term concern when escalating both at once — stagger/titrate carefully
No approved dosing protocol — investigational; use only under clinical/physician guidance
Combined class risks (pancreatitis, gallbladder, thyroid C-cell, elevated heart rate)
Not for pregnancy

Preparation & storage

Reconstitution: Reconstitute the blend vial (e.g. 10 mg total, 5+5) with 2 mL BAC water and dose by VOLUME per protocol.

Track Reta+Cagri Blend in Protokol.

Log doses, model half-lives, check interactions, and line it all up against your bloodwork. Free on iPhone and Android.